The Novel Soluble Guanylate Cyclase Stimulator Attenuates Acute Lung Injury via Inhibiting Pericyte Phenotypic Transition. [PDF]
Huang YL +12 more
europepmc +1 more source
Indirect Treatment Comparison of Riociguat Replacement Therapy and Selexipag Add-on Therapy in Patients With Pulmonary Arterial Hypertension: Results From a Systematic Review. [PDF]
An JE +10 more
europepmc +1 more source
Influence of Soluble Guanylate Cyclase on Cardiac, Vascular, and Renal Structure and Function: A Physiopathological Insight. [PDF]
De Feo D +7 more
europepmc +1 more source
Evidence Gap and Challenges in the Management of Mild Pulmonary Hypertension. [PDF]
Lin J, Gu X, Cai Z.
europepmc +1 more source
Effect of sildenafil on resting and exercise haemodynamics in hypoxia in patients with pulmonary vascular diseases: data from a randomised controlled trial. [PDF]
Lichtblau M +9 more
europepmc +1 more source
Pediatric Heart Failure Pharmacotherapy: Transformative Insights for the Future. [PDF]
Das BB.
europepmc +1 more source
Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort. [PDF]
Filla T +30 more
europepmc +1 more source
Emerging antihypertensive therapies and cardiovascular, kidney, and metabolic outcomes: a Mendelian randomization study. [PDF]
Le NN +4 more
europepmc +1 more source
Vericiguat Attenuates Vascular Calcification by Cyclic Guanosine Monophosphate-Protein Kinase G Pathway Mediated Suppression of Matrix Metalloproteinase 10. [PDF]
Hao QY +8 more
europepmc +1 more source

